Global Ulcerative Colitis Market Size, Status and Forecast 2020-2026

May 2020 | 98 pages | ID: G4AF01B05861EN
QYResearch

Abstracts

This report focuses on the global Ulcerative Colitis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ulcerative Colitis development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Johnson & Johnson.
• AbbVie
• Takeda Pharmaceuticals
• Roche
• Warner Chilcott
• Salix Pharmaceuticals/Santarus
• Takeda
• Ferring Pharmaceuticals
• Pfizer
• InDeX Pharmaceuticals

Market segment by Type, the product can be split into

• Oral
• Injection

Market segment by Application, split into

• Hospital
• Drugs Stores

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Ulcerative Colitis status, future forecast, growth opportunity, key market and key players.
• To present the Ulcerative Colitis development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Ulcerative Colitis are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ulcerative Colitis Revenue
1.4 Market Analysis by Type
  1.4.1 Global Ulcerative Colitis Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral
  1.4.3 Injection
1.5 Market by Application
  1.5.1 Global Ulcerative Colitis Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Drugs Stores
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Ulcerative Colitis Market Perspective (2015-2026)
2.2 Ulcerative Colitis Growth Trends by Regions
  2.2.1 Ulcerative Colitis Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Ulcerative Colitis Historic Market Share by Regions (2015-2020)
  2.2.3 Ulcerative Colitis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Ulcerative Colitis Market Growth Strategy
  2.3.6 Primary Interviews with Key Ulcerative Colitis Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Ulcerative Colitis Players by Market Size
  3.1.1 Global Top Ulcerative Colitis Players by Revenue (2015-2020)
  3.1.2 Global Ulcerative Colitis Revenue Market Share by Players (2015-2020)
  3.1.3 Global Ulcerative Colitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ulcerative Colitis Market Concentration Ratio
  3.2.1 Global Ulcerative Colitis Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Ulcerative Colitis Revenue in 2019
3.3 Ulcerative Colitis Key Players Head office and Area Served
3.4 Key Players Ulcerative Colitis Product Solution and Service
3.5 Date of Enter into Ulcerative Colitis Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Ulcerative Colitis Historic Market Size by Type (2015-2020)
4.2 Global Ulcerative Colitis Forecasted Market Size by Type (2021-2026)

5 ULCERATIVE COLITIS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Ulcerative Colitis Market Size by Application (2015-2020)
5.2 Global Ulcerative Colitis Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Ulcerative Colitis Market Size (2015-2020)
6.2 Ulcerative Colitis Key Players in North America (2019-2020)
6.3 North America Ulcerative Colitis Market Size by Type (2015-2020)
6.4 North America Ulcerative Colitis Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Ulcerative Colitis Market Size (2015-2020)
7.2 Ulcerative Colitis Key Players in Europe (2019-2020)
7.3 Europe Ulcerative Colitis Market Size by Type (2015-2020)
7.4 Europe Ulcerative Colitis Market Size by Application (2015-2020)

8 CHINA

8.1 China Ulcerative Colitis Market Size (2015-2020)
8.2 Ulcerative Colitis Key Players in China (2019-2020)
8.3 China Ulcerative Colitis Market Size by Type (2015-2020)
8.4 China Ulcerative Colitis Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Ulcerative Colitis Market Size (2015-2020)
9.2 Ulcerative Colitis Key Players in Japan (2019-2020)
9.3 Japan Ulcerative Colitis Market Size by Type (2015-2020)
9.4 Japan Ulcerative Colitis Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Ulcerative Colitis Market Size (2015-2020)
10.2 Ulcerative Colitis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ulcerative Colitis Market Size by Type (2015-2020)
10.4 Southeast Asia Ulcerative Colitis Market Size by Application (2015-2020)

11 INDIA

11.1 India Ulcerative Colitis Market Size (2015-2020)
11.2 Ulcerative Colitis Key Players in India (2019-2020)
11.3 India Ulcerative Colitis Market Size by Type (2015-2020)
11.4 India Ulcerative Colitis Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Ulcerative Colitis Market Size (2015-2020)
12.2 Ulcerative Colitis Key Players in Central & South America (2019-2020)
12.3 Central & South America Ulcerative Colitis Market Size by Type (2015-2020)
12.4 Central & South America Ulcerative Colitis Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Johnson & Johnson.
  13.1.1 Johnson & Johnson. Company Details
  13.1.2 Johnson & Johnson. Business Overview and Its Total Revenue
  13.1.3 Johnson & Johnson. Ulcerative Colitis Introduction
  13.1.4 Johnson & Johnson. Revenue in Ulcerative Colitis Business (2015-2020))
  13.1.5 Johnson & Johnson. Recent Development
13.2 AbbVie
  13.2.1 AbbVie Company Details
  13.2.2 AbbVie Business Overview and Its Total Revenue
  13.2.3 AbbVie Ulcerative Colitis Introduction
  13.2.4 AbbVie Revenue in Ulcerative Colitis Business (2015-2020)
  13.2.5 AbbVie Recent Development
13.3 Takeda Pharmaceuticals
  13.3.1 Takeda Pharmaceuticals Company Details
  13.3.2 Takeda Pharmaceuticals Business Overview and Its Total Revenue
  13.3.3 Takeda Pharmaceuticals Ulcerative Colitis Introduction
  13.3.4 Takeda Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020)
  13.3.5 Takeda Pharmaceuticals Recent Development
13.4 Roche
  13.4.1 Roche Company Details
  13.4.2 Roche Business Overview and Its Total Revenue
  13.4.3 Roche Ulcerative Colitis Introduction
  13.4.4 Roche Revenue in Ulcerative Colitis Business (2015-2020)
  13.4.5 Roche Recent Development
13.5 Warner Chilcott
  13.5.1 Warner Chilcott Company Details
  13.5.2 Warner Chilcott Business Overview and Its Total Revenue
  13.5.3 Warner Chilcott Ulcerative Colitis Introduction
  13.5.4 Warner Chilcott Revenue in Ulcerative Colitis Business (2015-2020)
  13.5.5 Warner Chilcott Recent Development
13.6 Salix Pharmaceuticals/Santarus
  13.6.1 Salix Pharmaceuticals/Santarus Company Details
  13.6.2 Salix Pharmaceuticals/Santarus Business Overview and Its Total Revenue
  13.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Introduction
  13.6.4 Salix Pharmaceuticals/Santarus Revenue in Ulcerative Colitis Business (2015-2020)
  13.6.5 Salix Pharmaceuticals/Santarus Recent Development
13.7 Takeda
  13.7.1 Takeda Company Details
  13.7.2 Takeda Business Overview and Its Total Revenue
  13.7.3 Takeda Ulcerative Colitis Introduction
  13.7.4 Takeda Revenue in Ulcerative Colitis Business (2015-2020)
  13.7.5 Takeda Recent Development
13.8 Ferring Pharmaceuticals
  13.8.1 Ferring Pharmaceuticals Company Details
  13.8.2 Ferring Pharmaceuticals Business Overview and Its Total Revenue
  13.8.3 Ferring Pharmaceuticals Ulcerative Colitis Introduction
  13.8.4 Ferring Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020)
  13.8.5 Ferring Pharmaceuticals Recent Development
13.9 Pfizer
  13.9.1 Pfizer Company Details
  13.9.2 Pfizer Business Overview and Its Total Revenue
  13.9.3 Pfizer Ulcerative Colitis Introduction
  13.9.4 Pfizer Revenue in Ulcerative Colitis Business (2015-2020)
  13.9.5 Pfizer Recent Development
13.10 InDeX Pharmaceuticals
  13.10.1 InDeX Pharmaceuticals Company Details
  13.10.2 InDeX Pharmaceuticals Business Overview and Its Total Revenue
  13.10.3 InDeX Pharmaceuticals Ulcerative Colitis Introduction
  13.10.4 InDeX Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020)
  13.10.5 InDeX Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Ulcerative Colitis Key Market Segments
Table 2. Key Players Covered: Ranking by Ulcerative Colitis Revenue
Table 3. Ranking of Global Top Ulcerative Colitis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ulcerative Colitis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Injection
Table 7. Global Ulcerative Colitis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Ulcerative Colitis Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Ulcerative Colitis Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Ulcerative Colitis Market Share by Regions (2015-2020)
Table 11. Global Ulcerative Colitis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Ulcerative Colitis Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Ulcerative Colitis Market Growth Strategy
Table 17. Main Points Interviewed from Key Ulcerative Colitis Players
Table 18. Global Ulcerative Colitis Revenue by Players (2015-2020) (Million US$)
Table 19. Global Ulcerative Colitis Market Share by Players (2015-2020)
Table 20. Global Top Ulcerative Colitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ulcerative Colitis as of 2019)
Table 21. Global Ulcerative Colitis by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Ulcerative Colitis Product Solution and Service
Table 24. Date of Enter into Ulcerative Colitis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 27. Global Ulcerative Colitis Market Size Share by Type (2015-2020)
Table 28. Global Ulcerative Colitis Revenue Market Share by Type (2021-2026)
Table 29. Global Ulcerative Colitis Market Size Share by Application (2015-2020)
Table 30. Global Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 31. Global Ulcerative Colitis Market Size Share by Application (2021-2026)
Table 32. North America Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Ulcerative Colitis Market Share (2019-2020)
Table 34. North America Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 35. North America Ulcerative Colitis Market Share by Type (2015-2020)
Table 36. North America Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 37. North America Ulcerative Colitis Market Share by Application (2015-2020)
Table 38. Europe Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Ulcerative Colitis Market Share (2019-2020)
Table 40. Europe Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Ulcerative Colitis Market Share by Type (2015-2020)
Table 42. Europe Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Ulcerative Colitis Market Share by Application (2015-2020)
Table 44. China Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 45. China Key Players Ulcerative Colitis Market Share (2019-2020)
Table 46. China Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 47. China Ulcerative Colitis Market Share by Type (2015-2020)
Table 48. China Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 49. China Ulcerative Colitis Market Share by Application (2015-2020)
Table 50. Japan Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Ulcerative Colitis Market Share (2019-2020)
Table 52. Japan Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Ulcerative Colitis Market Share by Type (2015-2020)
Table 54. Japan Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Ulcerative Colitis Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Ulcerative Colitis Market Share (2019-2020)
Table 58. Southeast Asia Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Ulcerative Colitis Market Share by Type (2015-2020)
Table 60. Southeast Asia Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Ulcerative Colitis Market Share by Application (2015-2020)
Table 62. India Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 63. India Key Players Ulcerative Colitis Market Share (2019-2020)
Table 64. India Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 65. India Ulcerative Colitis Market Share by Type (2015-2020)
Table 66. India Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 67. India Ulcerative Colitis Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Ulcerative Colitis Market Share (2019-2020)
Table 70. Central & South America Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Ulcerative Colitis Market Share by Type (2015-2020)
Table 72. Central & South America Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Ulcerative Colitis Market Share by Application (2015-2020)
Table 74. Johnson & Johnson. Company Details
Table 75. Johnson & Johnson. Business Overview
Table 76. Johnson & Johnson. Product
Table 77. Johnson & Johnson. Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 78. Johnson & Johnson. Recent Development
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Product
Table 82. AbbVie Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 83. AbbVie Recent Development
Table 84. Takeda Pharmaceuticals Company Details
Table 85. Takeda Pharmaceuticals Business Overview
Table 86. Takeda Pharmaceuticals Product
Table 87. Takeda Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 88. Takeda Pharmaceuticals Recent Development
Table 89. Roche Company Details
Table 90. Roche Business Overview
Table 91. Roche Product
Table 92. Roche Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 93. Roche Recent Development
Table 94. Warner Chilcott Company Details
Table 95. Warner Chilcott Business Overview
Table 96. Warner Chilcott Product
Table 97. Warner Chilcott Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 98. Warner Chilcott Recent Development
Table 99. Salix Pharmaceuticals/Santarus Company Details
Table 100. Salix Pharmaceuticals/Santarus Business Overview
Table 101. Salix Pharmaceuticals/Santarus Product
Table 102. Salix Pharmaceuticals/Santarus Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 103. Salix Pharmaceuticals/Santarus Recent Development
Table 104. Takeda Company Details
Table 105. Takeda Business Overview
Table 106. Takeda Product
Table 107. Takeda Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 108. Takeda Recent Development
Table 109. Ferring Pharmaceuticals Business Overview
Table 110. Ferring Pharmaceuticals Product
Table 111. Ferring Pharmaceuticals Company Details
Table 112. Ferring Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 113. Ferring Pharmaceuticals Recent Development
Table 114. Pfizer Company Details
Table 115. Pfizer Business Overview
Table 116. Pfizer Product
Table 117. Pfizer Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 118. Pfizer Recent Development
Table 119. InDeX Pharmaceuticals Company Details
Table 120. InDeX Pharmaceuticals Business Overview
Table 121. InDeX Pharmaceuticals Product
Table 122. InDeX Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 123. InDeX Pharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Ulcerative Colitis Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Ulcerative Colitis Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Drugs Stores Case Studies
Figure 7. Ulcerative Colitis Report Years Considered
Figure 8. Global Ulcerative Colitis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Ulcerative Colitis Market Share by Regions: 2020 VS 2026
Figure 10. Global Ulcerative Colitis Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Ulcerative Colitis Market Share by Players in 2019
Figure 13. Global Top Ulcerative Colitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ulcerative Colitis as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Ulcerative Colitis Revenue in 2019
Figure 15. North America Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Johnson & Johnson. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Johnson & Johnson. Revenue Growth Rate in Ulcerative Colitis Business (2015-2020)
Figure 24. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. AbbVie Revenue Growth Rate in Ulcerative Colitis Business (2015-2020)
Figure 26. Takeda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Takeda Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2015-2020)
Figure 28. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Roche Revenue Growth Rate in Ulcerative Colitis Business (2015-2020)
Figure 30. Warner Chilcott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Warner Chilcott Revenue Growth Rate in Ulcerative Colitis Business (2015-2020)
Figure 32. Salix Pharmaceuticals/Santarus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Salix Pharmaceuticals/Santarus Revenue Growth Rate in Ulcerative Colitis Business (2015-2020)
Figure 34. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Takeda Revenue Growth Rate in Ulcerative Colitis Business (2015-2020)
Figure 36. Ferring Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Ferring Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2015-2020)
Figure 38. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Pfizer Revenue Growth Rate in Ulcerative Colitis Business (2015-2020)
Figure 40. InDeX Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. InDeX Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed